Balancing Risks: The Core of Women's Decisions About Noninvasive Prenatal Testing

AJOB Empirical Bioethics

Volumn 6, Issue 1, 2015, Pages 42-53

  Farrell, Ruth M ^a   Agatisa, Patricia K ^a   Mercer, Mary Beth ^a   Smith, Marissa B ^a   Philipson, Elliot ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ethics; informed consent; patient education and counseling; prenatal genetic screening

Indexed keywords

EID: 84924355624     PISSN: 23294515     EISSN: 23294523     Source Type: Journal    
DOI: 10.1080/23294515.2014.993098     Document Type: Article

References (54)

1. Allyse, M. A., L. C. Sayres, T. A. Goodspeed, and M. K. Cho. 2014. Attitudes towards non-invasive prenatal testing aneuploidy among US adults of reproductive age. Journal of Perinatology 34: 429–34. http://dx.doi.org/10.1038/jp.2014.30
2. American College of Obstetricians and Gynecologists. 2007. ACOG practice bulletin. no. 77: Screening for fetal chromosomal abnormalities. Obstetrics and Gynecology 109(1): 217–27. http://dx.doi.org/10.1097/00006250-200701000-00054
3. American College of Obstetricians and Gynecologists. 2008. Committee opinion no. 410. Ethical issues in genetic testing. Obstetrics & Gynecology 111(6): 1495–502. http://dx.doi.org/10.1097/AOG.0b013e31817d252f
4. American College of Obstetricians and Gynecologists (ACOG) Committee on Genetics. 2012. Committee opinion no. 545.Noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology 120(6): 1532–4. http://dx.doi.org/10.1097/01.AOG.0000423819.85283.f4
5. Baillie, C., J. Smith, J. Hewison, and G. Mason. 2000. Ultrasound screening for chromosomal abnormality: Women's reactions to false positive results. British Journal of Health Psychology 5(4): 377–94. http://dx.doi.org/10.1348/135910700168991
6. Benn, P. A., and A. R. Chapman. 2009. Practical and ethical considerations of noninvasive prenatal diagnosis. Journal of the American Medical Association 30(20): 2154–56. http://dx.doi.org/10.1001/jama.2009.707
7. Bianchi, D. W., L. D. Platt, J. D. Goldberg, 2012. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology 119(5): 890–901. http://dx.doi.org/10.1097/AOG.0b013e31824fb482
8. Bianchi D. W., R. L. Parker, J. Wentworth, 2014. DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine 370(9): 799–808. http://dx.doi.org/10.1056/NEJMoa1311037
9. Birks, M., Y. Chapman, and K. Francis. 2008. Memoing in qualitative research: Probing data and processes. Journal of Research in Nursing 13(1): 68–75. http://dx.doi.org/10.1177/1744987107081254
10. Carroll, J. C., J. B. Brown, A. J. Reid, and P. Pugh. 2000. Women's experience of maternal serum screening. Canadian Family Physician 46(3): 614–20.
11. Chetty S., M. J. Garabedian, and M. E. Norton. 2013. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenatal Diagnosis 33(6): 542–6. http://dx.doi.org/10.1002/pd.4125
12. Chiu, R. W. K., K. C. Allen Chan, Y. Gao, 2008. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proceeding of the National Academy of Sciences of the United States of America 105(51): 20458–63. http://dx.doi.org/10.1073/pnas.0810641105
13. Chiu R. W. K., R. Akolekar, W. Zheng, 2011. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. British Medical Journal 342: c7401.
14. Corbin, J., and A. Strauss. 2008. Basics of qualitative research: Techniques and procedures for developing grounded theory (3rd ed.). Thousand Oakes, CA: Sage.
15. Curtin, S. C., J. C. Abma, S. J.Ventura, and S.K. Henshaw. 2013. National Center for Health Statistics; Pregnancy rates for U.S. women continue to drop. NCHS data brief, December. Washington, DC: U.S. Department of Health and Human Services.
16. Deans, Z., and A. J. Newson. 2011. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Analysis 19(2):122–32. http://dx.doi.org/10.1007/s10728-010-0146-8
17. de Jong, A., W. J. Dondorp, S. M. G. Frints, C. E. M. de Die-Smulders, and G. M. W. R. de Wert. 2011. Non-invasive prenatal diagnosis for aneuploidy: Toward an integral ethical assessment. Human Reproduction 26(11): 2915–7. http://dx.doi.org/10.1093/humrep/der268
18. Deverill, M. and S. Robson. 2006. Women's preferences in screening for Down syndrome. Prenatal Diagnosis 26(9): 837–41. http://dx.doi.org/10.1002/pd.1517
19. Devers, P. L., A. Cronister, K. E. Ormond, F. Facio, C. K. Brasington, and P. Flodman. 2013. Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the National Society of Genetic Counselors. Journal of Genetic Counseling 22(3): 291–5. http://dx.doi.org/10.1007/s10897-012-9564-0
20. Ehrich M, C. Deciu, T. Zwiefelhofer, 2011. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. American Journal of Obstetrics and Gynecology 204: 205.e1–.11. http://dx.doi.org/10.1016/j.ajog.2010.12.060
21. Fairbrother, G., S. Johnson, T. J. Musci, and K. Song. 2013. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenatal Diagnosis 33(6): 580–3. http://dx.doi.org/10.1002/pd.4092
22. Fan, H. C., and S. R. Quake. 2010. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shot-gun sequencing is limited only by counting statistics. PLoS ONE 5: e10439. http://dx.doi.org/10.1371/journal.pone.0010439
23. Gates, E.A. 2004. Communicating risk in prenatal genetic testing. Journal of Midwifery and Women's Health 49(3): 220–7. http://dx.doi.org/10.1016/j.jmwh.2004.02.014
24. Gregg, A. R., S. J. Gross, R. G. Best, 2013. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine 15(5): 395–8. http://dx.doi.org/10.1038/gim.2013.29
25. Hill, M. J., Fisher, L. S. Chitty, and S. Morris. 2012. Women's and health professionals’ preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genetics in Medicine 14(11): 905–13. http://dx.doi.org/10.1038/gim.2012.68
26. Kuppermann M., R. F. Nease, L. A. Learman, E. Gates, B. Blumberg, and A. E. Washington. 2000. Procedure-related miscarriages and Down syndrome-affected births: Implications for prenatal testing based on women's preferences. Obstetrics and Gynecology 96(4): 511–6. http://dx.doi.org/10.1016/S0029-7844(00)00969-8
27. Kuppermann M., L. A. Learman, E. Gates, 2006. Beyond race or ethnicity and socioeconomic status: Predictors of prenatal testing for Down syndrome. Obstetrics and Gynecology 107(5): 1087–97. http://dx.doi.org/10.1097/01.AOG.0000214953.90248.db
28. Learman L. A., M. Kuppermann, E. Gates, R. F. Nease, Jr., V. Gildengorin, and A. E. Washington. 2003. Social and familial context of prenatal genetic testing decisions: Are there racial/ethnic differences? American Journal of Medical Genetics 119C(1): 19–26. http://dx.doi.org/10.1002/ajmg.c.10004
29. Marteau, T.M. 1995. Towards informed decisions about prenatal testing: a review. Prenatal Diagnosis 15(13): 1215–26. http://dx.doi.org/10.1002/pd.1970151304
30. Marteau, T. M., R. Cook, J. Kidd, 1992. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenatal Diagnosis 12(3): 205–14. http://dx.doi.org/10.1002/pd.1970120309
31. Marteau, T. M., E. Dormandy, and S. Michie. 2001. A measure of informed choice. Health Expectations 4(2): 99–108. http://dx.doi.org/10.1046/j.1369-6513.2001.00140.x
32. Marteau T. M., J. Kidd, S. Michie, R. Cook, M. Johnston, and R. W. Shaw. 1993. Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: A randomized controlled trial. Journal of Psychosomatic Obstetrics and Gynecology 14(3): 185–96. http://dx.doi.org/10.3109/01674829309084441
33. Martin J. A., B. E. Hamilton, S. J. Ventura, 2011. Births: Final data for 2009. National Vital Statistics Report 60(1): 1–70.
34. Mattheis, P. J., F. Hickey, B. T. Tinkle, and R. Hopkin. 2008. Prenatal diagnosis: Beyond decisions about termination. Journal of Pediatrics 153(5): 728. http://dx.doi.org/10.1016/j.jpeds.2008.06.007
35. Matthews, T. J., and B. E. Hamilton. 2014. First births to older women continue to rise. NCHS data brief no. 152. Hyattsville, MD: National Center for Health Statistics.
36. McCabe L. L., and E. R. McCabe. 2012. Call for change in prenatal counseling for Down syndrome. American Journal of Medical Genetics Part A 158A(3): 482–4 http://dx.doi.org/10.1002/ajmg.a.35197
37. Mennuti, M. T., A. M. Cherry, J. D. Morrissette, and L. Dugoff, L. 2013. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? American Journal of Obstetrics and Gynecology 209(5): 415–9. http://dx.doi.org/10.1016/j.ajog.2013.03.027
38. Morain, S., M. F. Greene, and M. M. Mello. 2013. A new era in noninvasive prenatal testing. New England Journal of Medicine 369(6): 499–501. http://dx.doi.org/10.1056/NEJMp1304843
39. Newson, A.J. 2007. Ethical aspects arising from non-invasive fetal diagnosis. Seminars in Fetal and Neonatal Medicine 13(2): 103–8. http://dx.doi.org/10.1016/j.siny.2007.12.004
40. Norton, M.E., H. Brar, J. Weiss, 2012. Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.Obstetrics and Gynecology 207(2): 137.e1–.e8.
41. Pauker S.P. and S. G. Pauker. 1994. Prenatal diagnosis—Why is 35 a magic number? New England Journal of Medicine 330(16): 1151–2.
42. QSR International Pty Ltd. 2008. NVivo qualitative data analysis software, version 8.
43. Ralston, S. J., D. Wertz, D. Chelmow, S.D. Craigo, and D. W. Bianchi. 2001. Pregnancy outcomes after prenatal diagnosis of aneuploidy. Obstetrics and Gynecology 97(5 Pt 1): 729–33. http://dx.doi.org/10.1016/S0029-7844(01)01129-2
44. Rothman, B.K. 1994. The tentative pregnancy: Then and now. In Women and prenatal testing: Facing the challenges of genetic technology, eds. K. H. Rothenberg and E. J. Thomson, 260–70. Columbus, OH: Ohio State University Press
45. Ryan, G. and H. Bernard. 2003. Techniques to identify themes. Field Methods 15: 85–109. http://dx.doi.org/10.1177/1525822X02239569
46. Santalahti P., A. M. Latikka, M. Ryynanen, and E. Hemminki.1996. Women's experiences of prenatal serum screening. Birth 23(2): 101–7. http://dx.doi.org/10.1111/j.1523-536X.1996.tb00837.x
47. Sayres, L. C., M. Allyse, M. E. Norton, and M. K. Cho. 2011. Cell-free fetal DNA testing: A pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis 31(11): 1070–6. http://dx.doi.org/10.1002/pd.2835
48. Schmitz, D., C. Netzer, and W. Henn. 2009. An offer you can't refuse? Ethical implications of non-invasive prenatal diagnosis. Nature Reviews Genetics 10(8): 515. http://dx.doi.org/10.1038/nrg2631
49. Smith, D. K., R. W. Shaw, and T. M. Marteau. 1994. Informed consent to undergo serum screening for Down's syndrome: The gap between policy and practice. British Medical Journal 309(6957): 776. http://dx.doi.org/10.1136/bmj.309.6957.776
50. Spencer K., and D. Aitken. 2004. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstetrics and Gynecology 24(7): 735–9. http://dx.doi.org/10.1002/uog.1768
51. Tischler, R., L. Hudgins, Y. J. Blumenfeld, H. T. Greely, and K. E. Ormond. 2011. Noninvasive prenatal diagnosis: Pregnant women's interest and expected uptake. Prenatal Diagnosis 31(13): 1292–9. http://dx.doi.org/10.1002/pd.2888
52. Vahanian, S. A., M. Baraa Allaf, C. Yeh, M. R. Chavez, W. L. Kinzler, and A. M. Vintzileos. 2014. Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA. Journal of Maternal & Fetal Neonatal Medicine 27(1): 106–10. http://dx.doi.org/10.3109/14767058.2013.806477
53. van den Heuvel, A., L. Chitty, E. Dormandy, 2010. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Education and Counseling 78(1): 24–28. http://dx.doi.org/10.1016/j.pec.2009.05.014
54. Wapner R. J, D. A. Driscoll, and J. L. Simpson. 2012. Integration of microarray technology into prenatal diagnosis: Counseling issues generated during the NICHD clinical trial. Prenatal Diagnosis 32(4): 396–400. http://dx.doi.org/10.1002/pd.3863